The global medical industry experienced an 18% decline in the number of social responsibility-related patent applications in Q2 2024 compared with the previous quarter. The total number of social responsibility-related grants rose by 11% in Q2 2024, according to GlobalData’s Patent Analytics. GlobalData’s databook Medical Devices: Patents Trends Q2 2024 offers comprehensive insights into patenting trends, major players’ strategies, and geographical focus in the sector over the last three years. Buy the databook here.
Notably, the number of social responsibility-related patent applications in the medical industry was 92 in Q2 2024, versus 112 in the prior quarter.
The top five companies accounted for 13% of patenting activity
Analysis of patenting activity by companies shows that NIKE filed the most social responsibility patents within the medical industry in Q2 2024. The company filed 3 social responsibility-related patents in the quarter. It was followed by Cardinal Health with 3 social responsibility patent filings, Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk Onderzoek (2 filings), and Kikuchi Seisakusho (2 filings) in Q2 2024.
Patenting activity was driven by the US with a 26% share of total patent filings
The largest share of social responsibility related patent filings in the medical industry in Q2 2024 was in the US with 26%, followed by China (24%) and Japan (11%). The share represented by the US was 3% lower than the 29% share it accounted for in Q1 2024.
For further understanding of GlobalData's Medical Devices: Patents Trends Q2 2024, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.